World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
51672
World Ranking
8140
National Ranking
251

Laure Gossec publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Laure Gossec sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 892 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Laure Gossec D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Laure Gossec sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 100 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Laure Gossec is affiliated with Sorbonne University in France. Their research primarily focuses on the field of Medicine with particular specialization in Rheumatology, Immunology, and Hematology. The breadth of their work touches on both clinical and therapeutic aspects of autoimmune and inflammatory disorders.

The scientist's publication record includes significant work in several major scientific venues. Frequent publication venues include:

  • Annals of the Rheumatic Diseases
  • Revue du Rhumatisme
  • Lara D. Veeken
  • RMD Open
  • Joint Bone Spine

Their research topics cover various areas within rheumatology and related health conditions. Main topics addressed comprise:

  • Spondyloarthritis Studies and Treatments
  • Psoriasis: Treatment and Pathogenesis
  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • COVID-19 Clinical Research Studies

Frequent co-authors collaborating with Laure Gossec include:

  • Laura C. Coates
  • Anna Moltó
  • Pedro Machado
  • Philip J. Mease
  • Bruno Fautrel

Selected recent publications highlight the scope and impact of their research. These include:

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update (2020, Annals of the Rheumatic Diseases)
  • Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry (2020, Annals of the Rheumatic Diseases)
  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update (2020, Annals of the Rheumatic Diseases)
  • Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry (2021, Annals of the Rheumatic Diseases)
  • EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 (2020, Annals of the Rheumatic Diseases)

Their work contributes to developing clinical guidelines and recommendations, particularly in the context of rheumatoid arthritis, psoriatic arthritis, and rheumatic disease management during the COVID-19 pandemic. Research outputs also include analyses related to hospitalization and mortality risk in rheumatic patients affected by COVID-19.

Best Publications

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados

  • Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.

    Milena Gianfrancesco;Kimme L Hyrich;Sarah Al-Adely;Loreto Carmona

  • European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

    L Gossec;J S Smolen;S Ramiro;M de Wit

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

    Laure Gossec;Xenofon Baraliakos;Andreas Kerschbaumer;Maarten de Wit

  • Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

    Maarten Boers;John R. Kirwan;George Wells;Dorcas Beaton

  • Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

    Sofia Ramiro;Cécile Gaujoux-Viala;Jackie L Nam;Jackie L Nam;Josef S Smolen

  • Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

    Josef S Smolen;Monika Schöls;Jürgen Braun;Maxime Dougados

  • Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review

    Jérôme Avouac;Laure Gossec;Maxime Dougados

  • Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.

    Anja Strangfeld;Martin Schäfer;Milena A Gianfrancesco;Saskia Lawson-Tovey

  • Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

    Josef S. Smolen;Jürgen Braun;Maxime Dougados;Paul Emery

  • Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials

    Carine Salliot;Maxime Dougados;Laure Gossec

  • European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

    L Gossec;J S Smolen;C Gaujoux-Viala;Z Ash

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados

  • Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

    Cécile Gaujoux-Viala;Cécile Gaujoux-Viala;Josef S Smolen;Robert Landewé;Maxime Dougados

  • A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

    Laure Gossec;Maarten de Wit;Uta Kiltz;Juergen Braun

  • Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review

    Nadine Zeboulon;Maxime Dougados;Laure Gossec

  • Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis

    Jackie L Nam;Sofia Ramiro;Cecile Gaujoux-Viala;Kaoru Takase;Kaoru Takase

  • EULAR recommendations for patient education for people with inflammatory arthritis

    Heidi A. Zangi;Mwidimi Ndosi;Jo Adams;Lena Andersen

  • Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis.

    Sabrina Dadoun;Nadine Zeboulon-Ktorza;Christophe Combescure;Muriel Elhai

Frequent Co-Authors

Maxime Dougados
Maxime Dougados Hôpital Cochin
Bruno Fautrel
Bruno Fautrel Université Paris Cité
Alain Saraux
Alain Saraux University of Western Brittany
Josef S. Smolen
Josef S. Smolen Medical University of Vienna
Tore K. Kvien
Tore K. Kvien University of Oslo
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Robert Landewé
Robert Landewé University of Amsterdam
Francis Berenbaum
Francis Berenbaum Université Paris Cité
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Bernard Combe
Bernard Combe University of Montpellier

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine extends beyond traditional MD programs. Today, a wide range of online degrees offer flexible entry points into the healthcare field and support career growth. Nurses interested in mental health roles can consider fast track mental health nursing programs, which allow for quicker progression into specialized nurse practitioner positions.

For those aiming to lead in medical administration, pursuing one of the best online mha programs can open doors to hospital management or policy-making. Cost is often a barrier, but there are options among the cheapest mha online programs that deliver quality education without a high price tag.

Finally, nurses seeking advanced practice roles might look into msn to dnp programs online, which support progression to the highest levels of clinical nursing and leadership. Researching these pathways can help students find the most affordable, flexible, and relevant program to meet their career goals in the dynamic healthcare sector.

Best Scientists Citing Laure Gossec

Trending Scientists

Recently Published Articles